The Infection Control & Hospital Epidemiology medical journal has published the peer-reviewed DeMaND study. Singletto’s Dr. Tom Lendvay served as Lead Author.
Singletto Advisor Dr. Belinda Heyne shares DeMaND study results on Hospital News.
Dr. Belinda Heyne was recently featured in a CBC piece covering the DeMaND study’s findings and the life-giving potential of dye and light.
In collaboration with the WHO, CDC, and a consortium of labs around the world, Singletto founders Drs. Chen, Lendvay and Clark, conducted extensive research on the decontamination effects of the light-activated dye Methylene Blue on viruses, including SARS-CoV-2. The positive results of such study have been pre-published on medRxiv. Watch our video to learn more.